 |
|
|
|
 |
|
|
IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is a global non-profit NGO representing research-based pharmaceutical, biotech and vaccine companies and national industry associations in developed and developing countries.[1]
H5N1
The H5N1 pandemic threat has caused a vast increase in funding to influenza research.
The IFPMA's research-based vaccine manufacturing members are conducting a growing number of clinical trials of 'prototype' influenza vaccines, designed to counter to the threats of avian and pandemic influenza.[2]
See also
Notes
- ^ Medical News Today article WHO Commission Report On Biomedical Innovation, Patents And Public Health Contains Many Sound Proposals - But Underestimates Vital Role Of Patents published April 5, 2006
- ^ Medical News Today article There Are Thirty-One Avian & Pandemic Prototype Vaccines published May 2, 2006.
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "IFPMA". A list of authors is available in Wikipedia.
|
|
|
|
|
|
Top